Dr. Vinitha Philip-Cherian

Vinitha Philip-Cherian is a cancer researcher focused on translational oncology and precision medicine, with particular emphasis on hematological malignancies and solid tumors in the South African context. Her work centers on developing clinically relevant ex vivo platforms that bridge laboratory research and patient-specific therapeutic decision-making.

Her publications highlight the establishment of a drug sensitivity screening pipeline using patient-derived tumor cells, enabling identification of effective single agents and combination therapies. This research advances personalized treatment strategies for leukemia and other cancers by demonstrating variable drug responses within subtypes and uncovering novel therapeutic opportunities beyond conventional regimens.

Based on a limited but emerging body of publications, her contributions reflect strengths in functional precision oncology, collaborative clinical research, and implementation of locally grounded cancer innovation platforms. The work positions her within efforts to expand targeted cancer therapies and improve individualized care in resource-constrained settings.